5:24 PM
Sep 24, 2007
 |  BC Extra  |  Top Story

Bristol-Myers acquiring Adnexus

BMY will acquire Adnexus (Waltham, Mass.) for $430 million in cash. Adnexus is also eligible for $75 million in milestones. Adnexus' lead compound is Angiocept ( CT-322),...

Read the full 133 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >